Drug-induced sleep endoscopy (DISE) for non-CPAP treatment selection in patients with sleep-disordered breathing

Olivier M Vanderveken

doi:10.1007/s11325-012-0671-9

Abstract

Drug-induced sleep endoscopy (DISE) for non-CPAP treatment selection in patients with sleep-disordered breathing

Highlights

The aim of upper airway (UA) evaluation in patients with sleep-disordered breathing (SDB) is to gain a better insight into the complex pathophysiology of UA collapse and to improve treatment success rates while prospectively selecting the most appropriate therapeutic option for the individual patient [1]
Antwerp, Belgium e-mail: Olivier.Vanderveken@telenet.be used for the drug-induced sedation, while a consensus on Drug-induced sleep endoscopy (DISE) classification systems has not been established [3,4,5, 9]. In this issue of Sleep and Breathing, Eichler and colleagues compared the treatment recommendations that would be given after a clinical basic ENT examination (CBE) with the recommended therapy after conducting a DISE [10]
The results of the reported study indicate that DISE had a relevant impact on the treatment recommendation, and, could possibly change the success rates of non-CPAP therapy in SDB patients [10]

Summary

Introduction

The aim of upper airway (UA) evaluation in patients with sleep-disordered breathing (SDB) is to gain a better insight into the complex pathophysiology of UA collapse and to improve treatment success rates while prospectively selecting the most appropriate therapeutic option for the individual patient [1]. In this issue of Sleep and Breathing, Eichler and colleagues compared the treatment recommendations that would be given after a clinical basic ENT examination (CBE) with the recommended therapy after conducting a DISE [10]. The results of the reported study indicate that DISE had a relevant impact on the treatment recommendation, and, could possibly change the success rates of non-CPAP therapy in SDB patients [10].

Results

Conclusion